No Sex-Specific Differences in the Acute Antidepressant Actions of (R)-Ketamine in an Inflammation Model

被引:22
作者
Chang, Lijia [1 ]
Toki, Hidetoh [2 ]
Qu, Youge [1 ]
Fujita, Yuko [1 ]
Mizuno-Yasuhira, Akiko [2 ]
Yamaguchi, Jun-ichi [2 ]
Chaki, Shigeyuki [2 ]
Hashimoto, Kenji [1 ]
机构
[1] Chiba Univ, Div Clin Neurosci, Ctr Forens Mental Hlth, Chiba 2608670, Japan
[2] Taisho Pharmaceut Co Ltd, Res Headquarters, Saitama, Japan
关键词
(2R; 6R)-hydroxynorketamine; (R)-ketamine; sex-specific difference; SUSTAINED ANTIDEPRESSANT; RAPID-ONSET; R-KETAMINE; BRAIN;
D O I
10.1093/ijnp/pyy053
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Although previous reports suggest sex-specific differences in the antidepressant actions of (R,S)-ketamine, these differences in the antidepressant actions of (R)-ketamine, which is more potent than (S)-ketamine, are unknown. Methods: Saline or (R)-ketamine was administered 23 hours post lipopolysaccharide administration to adult male or female mice. Subsequently, antidepressant effects were assessed using a forced swimming test. Furthermore, the concentration of (R)-ketamine and its 2 major metabolites, (R)-norketamine and (2R,6R)-hydroxynorketamine, was measured in the plasma and brain after the administration of (R)-ketamine in the mice. Results: (R)-ketamine (10 mg/kg) significantly attenuated the increased immobility time of forced swimming test in the lipopolysaccharide-treated mice. There were no sex-specific differences in the concentrations of (R)-ketamine and its 2 metabolites in the plasma and brain. Conclusions: These findings showed no sex-specific differences in terms of the acute antidepressant effects and pharmacokinetic profile of (R)-ketamine.
引用
收藏
页码:932 / 937
页数:6
相关论文
共 26 条
[1]   What's the Buzz About Hydroxynorketamine? Is It the History, the Story, the Debate, or the Promise? [J].
Abdallah, Chadi G. .
BIOLOGICAL PSYCHIATRY, 2017, 81 (08) :E61-E63
[2]   Sex differences in the antidepressant-like effects of ketamine [J].
Carrier, Nicole ;
Kabbaj, Mohamed .
NEUROPHARMACOLOGY, 2013, 70 :27-34
[3]   Is Metabolism of (R)-Ketamine Essential for the Antidepressant Effects? [J].
Chaki, Shigeyuki .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2018, 21 (02) :154-156
[4]   Behavioral and biochemical sensitivity to low doses of ketamine: Influence of estrous cycle in C57BL/6 mice [J].
Dossat, Amanda M. ;
Wright, Katherine N. ;
Strong, Caroline E. ;
Kabbaj, Mohamed .
NEUROPHARMACOLOGY, 2018, 130 :30-41
[5]   Men and women differ in inflammatory and neuroendocrine responses to endotoxin but not in the severity of sickness symptoms [J].
Engler, Harald ;
Benson, Sven ;
Wegner, Alexander ;
Spreitzer, Ingo ;
Schedlowski, Manfred ;
Elsenbruch, Sigrid .
BRAIN BEHAVIOR AND IMMUNITY, 2016, 52 :18-26
[6]   Antidepressant Potential of (R)-Ketamine in Rodent Models: Comparison with (S)-Ketamine [J].
Fukumoto, Kenichi ;
Toki, Hidetoh ;
Iijima, Michihiko ;
Hashihayata, Takashi ;
Yamaguchi, Jun-ichi ;
Hashimoto, Kenji ;
Chaki, Shigeyuki .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2017, 361 (01) :9-16
[7]   R-ketamine: a rapid-onset and sustained antidepressant without risk of brain toxicity [J].
Hashimoto, K. .
PSYCHOLOGICAL MEDICINE, 2016, 46 (11) :2449-2451
[8]   What Are the Causes for Discrepancies of Antidepressant Actions of (2R, 6R)-Hydroxynorketamine? [J].
Hashimoto, Kenji ;
Shirayama, Yukihiko .
BIOLOGICAL PSYCHIATRY, 2018, 84 (01) :E7-E8
[9]   Ketamine's antidepressant action: beyond NMDA receptor inhibition [J].
Hashimoto, Kenji .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2016, 20 (11) :1389-1392
[10]   Reduction of dopamine D2/3 receptor binding in the striatum after a single administration of esketamine, but not R-ketamine: a PET study in conscious monkeys [J].
Hashimoto, Kenji ;
Kakiuchi, Takeharu ;
Ohba, Hiroyuki ;
Nishiyama, Shingo ;
Tsukada, Hideo .
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2017, 267 (02) :173-176